Home » Newsletters » BioWorld Science

BioWorld Science

May 4, 2007

View Archived Issues

New data provided by EAE models for multiple sclerosis

New clinical trial results for rotigotine in Parkinson's disease, restless legs syndrome

Antitumor activity of novel PI3K inhibitor reported by Zentaris

Novel CDK inhibitor SCH-727965 shows broad antitumor activity in preclinical studies

New therapeutic agents for benign prostatic hyperplasia disclosed in recent Ranbaxy patent

Recent data suggest that lacosamide has low potential for drug-drug interaction

Novel antiinfective agents disclosed in recent patent literature

Novel agents for cardiovascular disorders disclosed in recent Taisho and Boehringer patents

Biosite and Beckman Coulter amend merger agreement

Phase Ib study to begin for optimized TPM-02/Insulin

Cardiome Pharma in-licenses GED-aPC

Rituximab beneficial in myositis, polyneuropathy, neuromyelitis optica

Laquinimod reduces disease activity in relapsing-remitting MS

Phase III trial finds Imagify non-inferior to nuclear stress

Positive phase I findings for DG-051 for prevention of heart attack

Schering-Plough reviews Q1

TH-302 demonstrates activity in orthotopic models of cancer

Pro-Pharmaceuticals and Digna collaborate in hepatitis C

ViroPharma to establish European subsidiary for maribavir

Ark seeks clearance for phase III study of Trinam

ThromboGenics reviews preclinical pipelines progression

Target enrollment reached in phase IIb study of ozarelix for BPH

Cadence plans to increase patient numbers in phase III Omnigard trial

Enrollment under way in phase II study of FTY-720 for relapsing-remitting MS

Belinostat studied with doxorubicin in new phase I/II trial for soft tissue sarcomas

Enzon cleared to begin phase I study of PEG-SN38 in cancer

Tbeta4 cleared for phase II study in diabetics undergoing vitrectomy surgery

Herceptin approved for new breast cancer indication in E.U.

Supprelin-LA approved for central precocious puberty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...